We are live on ! Find out more
CRXT

Clarus Therapeutics Holdings, Inc. Common Stock
CRXT

Delisted

CRXT was delisted on the 30th of August, 2022.

Back to rankings

21 hedge funds and large institutions have $37.6M invested in Clarus Therapeutics Holdings, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+21
Holders Change %
–
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KIM
Karpus Investment Management
New York
+$7.04M
2
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$4.99M
3
CH
CVI Holdings
Delaware
+$4.03M
4
MP
Mangrove Partners
Connecticut
+$2.88M
5
MSU
Mizuho Securities USA
New York
+$2.86M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
KIM
1
Karpus Investment Management
New York
$7.03M +$7.04M +698,047 New
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$4.98M +$4.99M +495,000 New
CH
3
CVI Holdings
Delaware
$4.02M +$4.03M +400,000 New
MP
4
Mangrove Partners
Connecticut
$2.88M +$2.88M +285,460 New
MSU
5
Mizuho Securities USA
New York
$2.84M +$2.86M +283,918 New
PAMP
6
Polar Asset Management Partners
Ontario, Canada
$2.77M +$2.77M +275,000 New
RCM
7
Radcliffe Capital Management
Pennsylvania
$2.27M +$2.27M +225,000 New
BI
8
Bulldog Investors
New Jersey
$2.19M +$2.19M +217,070 New
SCM
9
Saba Capital Management
New York
$1.71M +$1.71M +170,018 New
Bank of America
10
Bank of America
North Carolina
$1.59M +$1.59M +158,125 New
PC
11
Periscope Capital
Ontario, Canada
$1.37M +$1.37M +135,800 New
RCM
12
Rivernorth Capital Management
Florida
$1.26M +$1.26M +125,000 New
AA
13
AQR Arbitrage
Connecticut
$604K +$605K +60,000 New
FTCM
14
Fir Tree Capital Management
New York
$437K +$438K +43,439 New
CCM
15
Context Capital Management
California
$400K +$400K +39,696 New
II
16
Ibex Investors
Colorado
$351K +$352K +34,900 New
DWM
17
Dakota Wealth Management
Florida
$337K +$338K +33,493 New
WAM
18
Wolverine Asset Management
Illinois
$239K +$240K +23,773 New
CCA
19
Cruiser Capital Advisors
Connecticut
$201K +$202K +20,000 New
SSA
20
Schonfeld Strategic Advisors
New York
$111K +$111K +10,974 New
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$19K +$18.6K +1,847 New

CRXT Hedge Fund Activity: Q1 2021 in Review

21 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Clarus Therapeutics Holdings, Inc. Common Stock (CRXT) for Q1 2021, worth a combined $37.6M.

Buyers outnumbered sellers: 21 funds opened new CRXT positions and 0 closed out — a net gain of 21 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Karpus Investment Management, opening a new position worth an estimated $7.04M.

  • 21 institutional investors held Clarus Therapeutics Holdings, Inc. Common Stock (CRXT) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $37.6M of Clarus Therapeutics Holdings, Inc. Common Stock stock for Q1 2021.
  • 21 funds opened new Clarus Therapeutics Holdings, Inc. Common Stock positions in Q1 2021 and 0 closed out, a net change of +21 holders.
  • The largest Clarus Therapeutics Holdings, Inc. Common Stock buyer in Q1 2021 was Karpus Investment Management, an estimated $7.04M added.

Based on aggregated 13F filings for Q1 2021.